Revenue | ₹61.33Cr |
Net Profits | ₹6.58Cr |
Net Profit Margins | 10.73% |
Jagsonpal Pharmaceuticals Ltd’s revenue jumped 33.41% since last year same period to ₹61.33Cr in the Q4 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -38.38% fall in its revenue since last 3-months.
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 85.35% since last year same period to ₹6.58Cr in the Q4 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -79.43% fall in its net profits since last 3-months.
Jagsonpal Pharmaceuticals Ltd’s net profit margin jumped 38.93% since last year same period to 10.73% in the Q4 2024-2025. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -66.62% fall in its net profit margins since last 3-months.
The revenue for Jagsonpal Pharmaceuticals Ltd in the Q4 results 2024 was ₹61.33Cr.
The net profit for Jagsonpal Pharmaceuticals Ltd in the Q4 results 2024 was ₹6.58Cr.
The net profit margin for Jagsonpal Pharmaceuticals Ltd in the Q4 results 2024 was 10.73%.
The revenue for Jagsonpal Pharmaceuticals Ltd in the Q4 results 2023 was ₹45.97Cr.
The net profit for Jagsonpal Pharmaceuticals Ltd in the Q4 results 2023 was ₹3.55Cr.
The net profit margin for Jagsonpal Pharmaceuticals Ltd in the Q4 results 2023 was 7.72%.